References
- Abid MR, Yi X, Yano K, Shih SC, Aird WC. 2006. Vascular endocan is preferentially expressed in tumor endothelium. Microvascular Research 72:136–145.
- Akinlade KS, Adediji IO, Rahamon SK, Fawole AO, Tongo OO. 2015. Serum copeptin and pregnancy outcome in preeclampsia. Nigerian Medical Journal 56:362–368.
- American Society for Reproductive Medicine (ASRM). 1996. Revised American Society for Reproductive Medicine classification of endometriosis. Fertility and Sterility 67:817–821.
- Gajbhiye R, Bendigeri T, Ghuge A, Bhusane K, Begum S, Warty N, et al. 2017. Panel of autoimmune markers for noninvasive diagnosis of minimal-mild endometriosis. Reproductive Sciences (Thousand Oaks, CA) 24:413–420.
- Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, et al. 2005. ESHRE guideline for the diagnosis and treatment of endometriosis. Human Reproduction (Oxford, England) 20:2698–2704.
- Letsiou S, Peterse DP, Fassbender A, Hendriks MM, van den Broek NJ, Berger R, et al. 2017. Endometriosis is associated with aberrant metabolite profiles in plasma. Fertility and Sterility 107:699–706. e6.
- Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F, et al. 1998. The performance of CA125 measurement in the detection of endometriosis: a metaanalysis. Fertility and Sterility 70:1101–1108.
- Pittaway D. 1997. Serum markers of endometrium and endometriosis. In: Diamond M, Osteen P, editors. Endometrium and endometriosis. Malden, MA: Blackwell Science. p. 112–117.
- Pochet NL, Suykens JA. 2006. Support vector machines versus logistic regression: improving prospective performance in clinical decision-making. Ultrasound in Obstetrics and Gynecology 27:607–608.
- Rocha AL, Vieira EL, Maia LM, Teixeira AL, Reis FM. 2016. Prospective evaluation of a panel of plasma cytokines and chemokines as potential markers of pelvic endometriosis in symptomatic women. Gynecologic and Obstetric Investigation 81:512–517.
- Rogers PA, D'Hooghe TM, Fazleabas A, Gargett CE, Giudice LC, Montgomery GW, et al. 2009. Priorities for endometriosis research: recommendations from an international consensus workshop. Reproductive Sciences (Thousand Oaks, CA) 16:335–346.
- Ruan YQ, Liang WG, Huang SH. 2015. Analysis of laparoscopy on endometriosis patients with high expression of CA125. European Review for Medical and Pharmacological Sciences. 19:1334–1337.
- Seeber B, Sammel MD, Fan X, Gerton GL, Shaunik A, Chittams J, et al. 2008. Panel of markers can accurately predict endometriosis in a subset of patients. Fertility and Sterility 89:1073–1081.
- Tuten A, Kucur M, Imamoglu M, Kaya B, Acikgoz AS, Yilmaz N, et al. 2014a. Copeptin is associated with the severity of endometriosis. Archives of Gynecology and Obstetrics 290:75–82.
- Tuten A, Kucur M, Imamoglu M, Oncul M, Acikgoz AS, Sofiyeva N, et al. 2014b. Serum YKL-40 levels are altered in endometriosis. Gynecological Endocrinology 30: 381–384.
- Tuten N, Acikgoz AS, Mammadov Z, Malik E, Tüten A, Güralp O. 2019. Is there a role of 25-OH vitamin D in pathogenesis of mild and moderate-to-severe endometriosis? Gynecology Obstetrics and Reproductive Medicine. DOI: 10.21613/GORM.2018.949.
- Vodolazkaia A, El-Aalamat Y, Popovic D, Mihalyi A, Bossuyt X, Kyama CM, et al. 2012. Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis. Human Reproduction (Oxford, England) 27:2698–2711.